Company Directory / research

OccuRx logo

PrivateFor profitresearchMelbourne, Australia

OccuRx

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

Founded
2014
12 years ago
Staff
1-10
band, as listed
Followers
-
on LinkedIn
Funding
$21M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

1-10 people: larger than 0% of companies with a size listed

Age

201419002026

12 years old.

Reach

Website ranked #14,268,985 in the world for traffic, about 55 visits a month.

What it does

BiopharmaBiotechnologyMedicalTherapeutics

Funding, as listed

$21M currency not stated

  • Rounds4
  • LatestSeries b, Sept 2022
  • Investors5, 4 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersDarren Kelly

Every detail we hold

Everything the source datasets list about OccuRx, field by field. Contact details are held but never shown.

The company

Name
OccuRx
Type
For profit
Status
Private
Founded
2014
Founders
Darren Kelly
Industry
research
Categories
Biopharma, Biotechnology, Medical, Therapeutics

Where

City
Melbourne
Country
Australia
Markets
Asia-Pacific (APAC), Australasia

Size and reach

Staff band
1-10
Web traffic rank
#14,268,985
Monthly web visits
55

Funding, as listed

Total
21,193,767 (currency not stated)
Rounds
4
Latest round
Series b
Latest round date
Sept 2022
Investors
5
Lead investors
4
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

OccuRx may be growing as it is listed among companies in the graft-versus-host disease market, which is expected to see an upsurge in growth during the forecast period. The company is also mentioned in the context of the Chronic Kidney Disease clinical trial pipeline, indicating active involvement in developing treatments in this area. Furthermore, OccuRx appears alongside other companies in a discussion about the growth potential of the Chronic Kidney Disease pipeline domain, suggesting that it is part of a sector that is anticipating growth.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in Australia.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.